IGM Biosciences, Inc. (IGMS)

NASDAQ: IGMS · Real-Time Price · USD

1.080

-0.140 (-11.48%)

At close: Jun 27, 2025, 4:00 PM

1.180

+0.100 (9.26%)

After-hours: Jun 27, 2025, 7:11 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Engineered Immunoglobulin M Antibodies	2.13M	Log In
Engineered Immunoglobulin M Antibodies Growth	99.25%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	2.13M	Log In
United States Growth	99.25%	Log In